Moreover, the observation that CANTumor mice had significantly higher CD4+/CD8+ T cell ratios compared to CANRegress and CANReject groups suggested underlying differences in immune functioning and susceptibility to tumour development and maintenance (Figure 4C). The gene discussed is CD8A; the disease is neoplasm.